Literature DB >> 19953115

Neuro-oncology: late neurocognitive decline after radiotherapy for low-grade glioma.

Mustafa Khasraw, Andrew B Lassman.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19953115     DOI： 10.1038/nrneurol.2009.194

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  9 in total

1.  Loss of heterozygosity 1p36 and 19q13 is a prognostic factor for overall survival in patients with diffuse WHO grade 2 gliomas treated without chemotherapy.

Authors:  Luigi Mariani; Gianluca Deiana; Erik Vassella; Ali-Reza Fathi; Christine Murtin; Marlène Arnold; Istvan Vajtai; Joachim Weis; Peter Siegenthaler; Martina Schobesberger; Michael M Reinert
Journal:  J Clin Oncol       Date:  2006-09-11       Impact factor: 44.544

2.  Cognitive and radiological effects of radiotherapy in patients with low-grade glioma: long-term follow-up.

Authors:  Linda Douw; Martin Klein; Selene Saa Fagel; Josje van den Heuvel; Martin Jb Taphoorn; Neil K Aaronson; Tjeerd J Postma; W Peter Vandertop; Jacob J Mooij; Rudolf H Boerman; Guus N Beute; Jasper D Sluimer; Ben J Slotman; Jaap C Reijneveld; Jan J Heimans
Journal:  Lancet Neurol       Date:  2009-08-07       Impact factor: 44.182

3.  Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study.

Authors:  M Klein; J J Heimans; N K Aaronson; H M van der Ploeg; J Grit; M Muller; T J Postma; J J Mooij; R H Boerman; G N Beute; G J Ossenkoppele; G W van Imhoff; A W Dekker; J Jolles; B J Slotman; H Struikmans; M J B Taphoorn
Journal:  Lancet       Date:  2002-11-02       Impact factor: 79.321

4.  Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial.

Authors:  M J van den Bent; D Afra; O de Witte; M Ben Hassel; S Schraub; K Hoang-Xuan; P-O Malmström; L Collette; M Piérart; R Mirimanoff; A B M F Karim
Journal:  Lancet       Date:  2005 Sep 17-23       Impact factor: 79.321

5.  Prognostic factors for survival in adult patients with cerebral low-grade glioma.

Authors:  Francesco Pignatti; Martin van den Bent; Desmond Curran; Channa Debruyne; Richard Sylvester; Patrick Therasse; Denes Afra; Philippe Cornu; Michel Bolla; Charles Vecht; Abul B M F Karim
Journal:  J Clin Oncol       Date:  2002-04-15       Impact factor: 44.544

6.  Long-term outcome of low-grade oligodendroglioma and mixed glioma.

Authors:  J D Olson; E Riedel; L M DeAngelis
Journal:  Neurology       Date:  2000-04-11       Impact factor: 9.910

7.  Radiation-induced dementia in patients cured of brain metastases.

Authors:  L M DeAngelis; J Y Delattre; J B Posner
Journal:  Neurology       Date:  1989-06       Impact factor: 9.910

8.  Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial.

Authors:  R A Patchell; P A Tibbs; W F Regine; R J Dempsey; M Mohiuddin; R J Kryscio; W R Markesbery; K A Foon; B Young
Journal:  JAMA       Date:  1998-11-04       Impact factor: 56.272

9.  Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas.

Authors:  Justin S Smith; Edward F Chang; Kathleen R Lamborn; Susan M Chang; Michael D Prados; Soonmee Cha; Tarik Tihan; Scott Vandenberg; Michael W McDermott; Mitchel S Berger
Journal:  J Clin Oncol       Date:  2008-03-10       Impact factor: 44.544
  9 in total
  15 in total

Review 1.  IDH wild-type WHO grade II diffuse low-grade gliomas. A heterogeneous family with different outcomes. Systematic review and meta-analysis.

Authors:  Davide Tiziano Di Carlo; Hugues Duffau; Federico Cagnazzo; Nicola Benedetto; Riccardo Morganti; Paolo Perrini
Journal:  Neurosurg Rev       Date:  2018-06-26       Impact factor: 3.042

2.  microRNA-200a downregulation in human glioma leads to Gαi1 over-expression, Akt activation, and cell proliferation.

Authors:  Yuan-Yuan Liu; Min-Bin Chen; Long Cheng; Zhi-Qing Zhang; Zheng-Quan Yu; Qin Jiang; Gang Chen; Cong Cao
Journal:  Oncogene       Date:  2018-03-09       Impact factor: 9.867

Review 3.  Controversies in the Therapy of Low-Grade Gliomas.

Authors:  Ivan D Carabenciov; Jan C Buckner
Journal:  Curr Treat Options Oncol       Date:  2019-03-14

4.  Radiotherapy in adult low-grade glioma: nationwide trends in treatment and outcomes.

Authors:  R S Nunna; S Khalid; J S Ryoo; A Sethi; R W Byrne; A I Mehta
Journal:  Clin Transl Oncol       Date:  2020-07-20       Impact factor: 3.405

Review 5.  Low-grade gliomas.

Authors:  Deborah A Forst; Brian V Nahed; Jay S Loeffler; Tracy T Batchelor
Journal:  Oncologist       Date:  2014-03-24

6.  ROS-p53-cyclophilin-D signaling mediates salinomycin-induced glioma cell necrosis.

Authors:  Li-sen Qin; Pi-feng Jia; Zhi-qing Zhang; Shi-ming Zhang
Journal:  J Exp Clin Cancer Res       Date:  2015-05-30

Review 7.  Emerging pharmacotherapy for cancer patients with cognitive dysfunction.

Authors:  Justin Davis; Fiona M Ahlberg; Michael Berk; David M Ashley; Mustafa Khasraw
Journal:  BMC Neurol       Date:  2013-10-24       Impact factor: 2.474

8.  GSK621 Targets Glioma Cells via Activating AMP-Activated Protein Kinase Signalings.

Authors:  Hong Jiang; Wei Liu; Shi-Kun Zhan; Yi-Xin Pan; Liu-Guan Bian; Bomin Sun; Qing-Fang Sun; Si-Jian Pan
Journal:  PLoS One       Date:  2016-08-17       Impact factor: 3.240

9.  microRNA-153 Targets mTORC2 Component Rictor to Inhibit Glioma Cells.

Authors:  Yan Cui; Jizong Zhao; Lei Yi; Yugang Jiang
Journal:  PLoS One       Date:  2016-06-13       Impact factor: 3.240

Review 10.  Using lithium as a neuroprotective agent in patients with cancer.

Authors:  Mustafa Khasraw; David Ashley; Greg Wheeler; Michael Berk
Journal:  BMC Med       Date:  2012-11-02       Impact factor: 8.775
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.